Michal Masařík

Michal Masařík has been leading the ICRC since the summer of 2024. He earned his Ph.D. from the Faculty of Science at Masaryk University, specializing in Molecular and Cell Biology. He completed his habilitation in Pathological Physiology in 2019 at the Faculty of Medicine of Masaryk University in Brno. His professional career is deeply rooted in both scientific research and academia. He spent five years as a research scientist at the Institute of Biophysics of the Czech Academy of Sciences before returning to his alma mater, Masaryk University, in 2007. There, at the Faculty of Medicine in the Department of Pathological Physiology, he initially held the position of assistant professor, then associate professor, and in 2021, he was appointed as a full professor upon the recommendation of the Academic Council of Palacký University in Olomouc.

As a scientist, Michal Masařík specializes in tumor biology, with a particular focus on the tumor microenvironment, especially the mechanisms underlying resistance to therapy, and new agents that prevent tumor cell migration. At the Faculty of Medicine, he leads his own research team, the Masarik Cancer Research Lab.

His projects encompass both fundamental and translational research, with results that are applied in clinical diagnostics and cancer treatment. He is the author or co-author of numerous original research articles in international journals. Masařík is also a university lecturer and a co-author of online learning materials and teaching scripts. Since 2016, he has been a member of The European Association for Cancer Research.